Scientists Find Physical Clue to Rising Colon Cancer in Young Adults

For years, the surge in colorectal cancer among younger adults has baffled oncologists. While rates have fallen steadily in people over 65—thanks largely to widespread screening—the disease has been climbing relentlessly in those under 50, a demographic once considered virtually immune. Now, two converging lines of research are delivering the first tangible answers: one reveals that the colons of younger cancer patients are physically different from those of older patients, and another traces the origins of the disease to a bacterial toxin encountered in childhood.

Together, these findings are reshaping the scientific understanding of a disease that is now the leading cause of cancer death in American men under 50, and the second leading cause in young women [1].

A Disease in Reverse

The numbers tell a stark story. In 1995, roughly 11% of colorectal cancer diagnoses occurred in adults younger than 55. By 2019, that figure had doubled to 20%—one in five [2]. Among people in their 20s, incidence rates nearly tripled between 1990 and 2016, rising from 0.8 to 2.3 cases per 100,000 [3]. For those aged 30 to 39, rates climbed from 2.8 to 6.4 cases per 100,000 during roughly the same period [3].

Source: PMC / NCI SEER Data

Data as of Mar 12, 2026CSV

The trajectory is moving in precisely the wrong direction. While overall cancer mortality in Americans under 50 fell 44% between 1990 and 2023—from 25.5 to 14.2 deaths per 100,000—colorectal cancer mortality in the same group has increased 1.1% annually since 2005 [1]. Lung cancer deaths in young adults plummeted 5.7% per year; leukemia deaths fell 2.3%. Colorectal cancer is the sole top-five cancer moving the other direction [1].

The crisis extends well beyond the United States. A 2024 analysis published in The Lancet Oncology found early-onset colorectal cancer rising in 27 of 50 countries and territories examined, with the increase either exclusive to younger populations or accelerating faster than in older adults in 20 of those 27 nations [4].

Without intervention, researchers project the early-onset incidence rate will double by 2030, with 10.9% of all colon cancers and 22.9% of all rectal cancers diagnosed in young adults [5].

The Stiffness Discovery

In January 2026, a team of bioengineers at the University of Texas at Dallas and UT Southwestern Medical Center published a finding that immediately drew international attention. Led by Dr. Jacopo Ferruzzi, an assistant professor of bioengineering at UT Dallas, and Dr. Emina Huang, executive vice chair of research for surgery at UT Southwestern, the researchers performed biomechanical testing on colon tissue from 33 colorectal cancer patients—19 over the age of 50 and 14 under 50 [6][7].

The results were striking. Both cancerous and noncancerous colon tissue from the younger patients was significantly stiffer than tissue from the older patients. The younger tissue exhibited fibrotic characteristics, with elevated collagen content and structural changes consistent with chronic scarring [6].

"We were surprised to find that both healthy and cancerous tissues from these younger patients were stiffer than those from older patients," Dr. Ferruzzi said [6].

The team went further, growing patient-derived organoids—miniaturized 3D microtissues that replicate the structure and behavior of actual colon tissue—in environments of varying stiffness. The organoid experiments confirmed that a stiff mechanical environment drives cancer cells to proliferate at a faster rate, regardless of whether the original tissue donor was young or old [7].

"This is the first study to highlight the key role of biomechanical forces in the pathogenesis," Dr. Ferruzzi said of the findings, published in the journal Advanced Science [7]. Dr. Huang added: "We consider this study a significant advancement toward identifying those at risk" [7].

The implication is profound: something is causing chronic inflammation in the colons of younger people, leading to fibrosis and tissue stiffening that creates a fertile environment for tumors to form and grow. The question becomes: what is driving that inflammation?

A Toxin from Childhood

Six months before the stiffness study, a separate international research effort offered a complementary piece of the puzzle. Published in Nature in April 2025 and led by UC San Diego bioengineering professor Ludmil Alexandrov, the study analyzed 981 colorectal cancer genomes from patients across 11 countries [8].

The researchers identified a distinctive pattern of DNA mutations caused by colibactin, a toxin produced by certain strains of Escherichia coli that reside in the human colon. Colibactin-related mutational signatures were 3.3 times more prevalent in patients diagnosed before age 40 than in those diagnosed after age 70 [8].

Most remarkably, by molecularly timing the mutations, the team determined they had originated during the first decade of life. Colibactin-related mutations accounted for approximately 15% of APC driver mutations—among the earliest genetic alterations that directly promote cancer development [8].

"Exposure in early childhood could push cancer diagnosis from age 60 to age 40," Alexandrov noted [8]. The finding suggests that the seeds of early-onset colorectal cancer may be planted decades before any symptoms appear.

The study also revealed striking geographic variations. Colibactin-associated mutations were particularly prevalent in patients from Argentina, Brazil, Colombia, Russia, and Thailand, suggesting region-specific environmental or microbial exposures may be compounding the risk [8].

Researchers have several hypotheses about why colibactin exposure may be increasing in younger generations: the rise in cesarean births may alter how babies' gut bacteria develop; declining breastfeeding rates could affect the infant microbiome; increased antibiotic use in early childhood may eliminate protective bacteria while leaving colibactin-producing E. coli strains unchecked; and diets increasingly dominated by ultra-processed foods may further disrupt microbial balance [8][9].

The Ultra-Processed Food Connection

The dietary thread runs through nearly every investigation of early-onset colorectal cancer. A major study published in JAMA Oncology in November 2025, led by Dr. Andrew Chan at Massachusetts General Brigham, tracked more than 29,000 women from the Nurses' Health Study II over 24 years. Women under 50 whose diets contained the largest amounts of ultra-processed foods—roughly one-third of daily calories—were approximately 1.5 times more likely to develop precancerous adenomas compared to those who consumed the least [10].

Source: GDELT Project

Data as of Mar 12, 2026CSV

The mechanism appears to involve a cascade of interconnected biological disruptions. Ultra-processed foods alter the gut microbiome, creating an imbalance between protective bacteria that suppress inflammation and harmful bacteria that promote it. This chronic, low-grade inflammation can drive the tissue stiffening and fibrosis documented in the UT Dallas study, while also accelerating the accumulation of DNA damage like the colibactin-associated mutations identified by the UC San Diego team [9][10].

U.S. consumption of ultra-processed foods has risen sharply over the past several decades in a pattern that closely mirrors the increase in early-onset colorectal cancer cases [10]. Only 10% to 20% of early-onset colorectal cancers are attributable to inherited genetic factors, underscoring the dominant role of environmental and lifestyle exposures [11].

Biological Age vs. Chronological Age

An additional dimension of the problem emerged from research by Yin Cao at Washington University School of Medicine in St. Louis, who analyzed UK Biobank data from 148,724 participants. The study found that young adults diagnosed with colorectal cancer were, on average, biologically 15 years older than their chronological age [5].

This accelerated biological aging—driven by factors including poor diet, sedentary behavior, obesity, and environmental exposures—may explain why cancers typically associated with aging are now appearing decades earlier. The finding aligns with clinical observations that early-onset tumors tend to be more aggressive: three in four people under 50 are diagnosed with advanced disease, and tumors in younger patients are more likely to exhibit poorly differentiated features, signet ring cell histology, and lymphovascular invasion [5][11].

The Screening Dilemma

In response to rising incidence, both the American Cancer Society and the U.S. Preventive Services Task Force lowered the recommended age for routine colorectal cancer screening from 50 to 45. The shift was grounded in modeling studies showing that the risk of colorectal cancer at age 45 today is comparable to the risk at age 50 roughly two decades ago [12].

Yet implementation has been uneven. Less than 60% of eligible candidates currently receive recommended screening [5], and a recent real-world cohort analysis found that the guideline change has not yet produced a clinically meaningful improvement in earlier detection among newly targeted patients [12].

The diagnostic delay problem compounds the screening gap. The average time from symptom onset to diagnosis in young adults is approximately six months [5], partly because both patients and primary care physicians are less likely to suspect colorectal cancer in someone in their 20s or 30s. Symptoms like rectal bleeding, changes in bowel habits, and abdominal pain are frequently attributed to hemorrhoids, irritable bowel syndrome, or stress.

"If anyone has any change in their bowel habits, if they have any bleeding—even if they think it's a hemorrhoid, and it doesn't go away—just get a colonoscopy," said Dr. Vikram Reddy, a colorectal surgeon at Yale Medicine [2].

Converging Toward Answers

What makes the current moment significant is the convergence of these findings. For years, researchers could only point to broad correlations—diet, obesity, sedentary lifestyles—without identifying the precise biological mechanisms connecting them to cancer. The 2025-2026 studies begin to close that gap.

The colibactin research demonstrates that specific, identifiable DNA damage occurring in childhood can set the stage for cancer decades later. The tissue stiffness research shows that chronic inflammation creates a physical microenvironment that accelerates tumor growth. And the ultra-processed food studies reveal a plausible upstream driver of both the microbial disruption and the inflammatory response.

The UC San Diego team is now developing early detection tests that analyze stool samples for colibactin-related mutations, which could identify at-risk individuals long before cancer develops [8]. The UT Dallas researchers are exploring whether tissue stiffness could serve as a biomarker for cancer susceptibility, potentially enabling risk stratification through non-invasive imaging [6][7].

These advances arrive with urgency. The American Cancer Society estimates that in 2026 alone, approximately 108,860 new cases of colorectal cancer will be diagnosed in the United States, with roughly 55,230 deaths [13]. Without a reversal in current trends, colorectal cancer is projected to become the leading cause of cancer-related death for all adults in their 20s, 30s, and 40s by 2030 [2].

What Can Be Done Now

While the science catches up, the existing evidence points to actionable steps. Reducing ultra-processed food consumption, increasing dietary fiber, maintaining a healthy weight, limiting alcohol intake, and staying physically active all lower colorectal cancer risk [2][9]. For individuals with a family history of the disease, screening should begin at age 40—or ten years before the age at which a relative was diagnosed, whichever is earlier [2].

Perhaps most critically, symptoms should not be dismissed because of age. Rectal bleeding, persistent changes in bowel habits lasting more than two weeks, unexplained weight loss, chronic fatigue, and dark or ribbon-like stools all warrant prompt medical evaluation [2][5].

The mystery of why colorectal cancer is surging in young people is not yet fully solved. But for the first time, scientists can point to specific physical and molecular mechanisms rather than general risk factors. The stiffening colon, the childhood toxin, the disrupted microbiome—these are not abstract theories. They are measurable biological realities that are opening the door to targeted prevention, earlier detection, and ultimately, a reversal of one of the most alarming cancer trends of the 21st century.